The slopes with respect to brain amylin levels appear different between the groups, suggesting that, in a larger cohort that includes individuals without diabetes, there may occur effect modification, and the measures of association in the subgroups may differ from one another. This evidence concerns the gene IAPP and diabetes mellitus.